<VariationArchive RecordType="classified" VariationID="1328439" VariationName="GRCh37/hg19 17p13.3(chr17:1145231-1499243)x1" VariationType="copy number loss" Accession="VCV001328439" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-04-09" DateCreated="2021-12-18" MostRecentSubmission="2021-12-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1319054" VariationID="1328439">
      <GeneList>
        <Gene Symbol="BHLHA9" FullName="basic helix-loop-helix family member a9" GeneID="727857" HGNC_ID="HGNC:35126" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="1270444" stop="1271815" display_start="1270444" display_stop="1271815" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1173857" stop="1174564" display_start="1173857" display_stop="1174564" Strand="+" />
          </Location>
          <OMIM>615416</OMIM>
        </Gene>
        <Gene Symbol="CRK" FullName="CRK proto-oncogene, adaptor protein" GeneID="1398" HGNC_ID="HGNC:2362" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="1420693" stop="1456232" display_start="1420693" display_stop="1456232" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NT_187613.1" start="362719" stop="379185" display_start="362719" display_stop="379185" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1324646" stop="1359560" display_start="1324646" display_stop="1359560" Strand="-" />
          </Location>
          <OMIM>164762</OMIM>
        </Gene>
        <Gene Symbol="INPP5K" FullName="inositol polyphosphate-5-phosphatase K" GeneID="51763" HGNC_ID="HGNC:33882" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="1494577" stop="1516612" display_start="1494577" display_stop="1516612" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1397870" stop="1420181" display_start="1397870" display_stop="1420181" Strand="-" />
          </Location>
          <OMIM>607875</OMIM>
        </Gene>
        <Gene Symbol="MYO1C" FullName="myosin IC" GeneID="4641" HGNC_ID="HGNC:7597" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="1464186" stop="1492686" display_start="1464186" display_stop="1492686" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1367479" stop="1396000" display_start="1367479" display_stop="1396000" Strand="-" />
          </Location>
          <OMIM>606538</OMIM>
        </Gene>
        <Gene Symbol="PITPNA" FullName="phosphatidylinositol transfer protein alpha" GeneID="5306" HGNC_ID="HGNC:9001" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="1517718" stop="1562792" display_start="1517718" display_stop="1562792" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1421282" stop="1466109" display_start="1421282" display_stop="1466109" Strand="-" />
          </Location>
          <OMIM>600174</OMIM>
          <Haploinsufficiency last_evaluated="2012-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PITPNA">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PITPNA">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SLC43A2" FullName="solute carrier family 43 member 2" GeneID="124935" HGNC_ID="HGNC:23087" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="1569254" stop="1630088" display_start="1569254" display_stop="1630088" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NT_187611.1" start="1" stop="58862" display_start="1" display_stop="58862" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1477695" stop="1532129" display_start="1477695" display_stop="1532129" Strand="-" />
          </Location>
          <OMIM>610791</OMIM>
        </Gene>
        <Gene Symbol="TRARG1" FullName="trafficking regulator of GLUT4 (SLC2A4) 1" GeneID="286753" HGNC_ID="HGNC:29592" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="1279662" stop="1300978" display_start="1279662" display_stop="1300978" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1182956" stop="1204280" display_start="1182956" display_stop="1204280" Strand="+" />
          </Location>
          <OMIM>612211</OMIM>
        </Gene>
        <Gene Symbol="YWHAE" FullName="tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon" GeneID="7531" HGNC_ID="HGNC:12851" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="1344275" stop="1400222" display_start="1344275" display_stop="1400222" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NT_187613.1" start="286301" stop="342248" display_start="286301" display_stop="342248" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1247833" stop="1303555" display_start="1247833" display_stop="1303555" Strand="-" />
          </Location>
          <OMIM>605066</OMIM>
          <Haploinsufficiency last_evaluated="2014-06-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=YWHAE">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2014-06-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=YWHAE">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 17p13.3(chr17:1145231-1499243)x1</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>17p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="1145231" stop="1499243" display_start="1145231" display_stop="1499243" variantLength="354013" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 17p13.3(chr17:1145231-1499243)x1 AND not provided" Accession="RCV001795837" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-01-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-01-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-12-18" MostRecentSubmission="2021-12-18">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19584063</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20452996</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20599530</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21841781</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24174537</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28542865</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3992780" SubmissionDate="2021-12-16" DateLastUpdated="2021-12-18" DateCreated="2021-12-18">
        <ClinVarSubmissionID localKey="1791033" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002037161" DateUpdated="2021-12-18" DateCreated="2021-12-18" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19584063</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20452996</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20599530</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21841781</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24174537</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28542865</ID>
          </Citation>
          <Comment>This CNV is a 354 kb deletion of 17p13.3, on chromosome 17, (seq[GRCh37]del(17)(p13.3); chr17:g.1145231_1499243del), which is found in a de novo state. This CNV constitutes a loss encompassing the following protein coding genes: ABR, BHLHA9, CRK, INPP5K, MYO1C, TRARG1, and YWHAE (for which multiple haploinsufficiency predictors predict dosage sensitivity). The 17p13.3 chromosomal region is highly susceptible to rearrangements due to the presence of multiple low copy repeats. Larger deletions of 17p13.3, which fully encompass this CNV, and include both the PAFAH1B1 (aka LIS1) and YWHAE genes, are associated with the well described 17p13.3 deletion syndrome. 17p13.3 deletion syndrome includes Miller-Dieker syndrome (MDS), with the PAFAH1B1 gene associated with the lissencephaly phenotype. Bruno et al. (2009) identified a critical region of 258 kb including both the CRK and YWHAE genes as being responsible for distinctive facial dysmorphisms associated with deletions in this region. The 354 kb loss does not remove the PAFAH1B1 gene but does result in loss of both the CRK and YWHAE genes. Losses with similar gene deletions, including the YWHAE and/or the CRK genes, have been reported in at least six individuals (Nagamani et al. 2009; Bruno et al. 2010; Schiff et al. 2010; Noor et al. 2018; Romano et al. 2020). Phenotypic presentation is variable, but common phenotypes described in the six individuals include developmental delays and learning disability, variable brain malformations (not including lissencephaly), and dysmorphic facial features. Other reported phenotypes include epilepsy, infantile spasms, feeding difficulties, growth restriction, hypotonia, anteriorly placed anus, vesico-ureteral reflux, hydronephrosis, and arthrogryposis of upper limbs. Heterozygous deletions at 17p13.3 typically occur de novo, although inherited cases are described, and follow and autosomal dominant mode of inheritance. Three of the individuals carried confirmed de novo losses, one individual carried an assumed de novo loss, while the fifth individual lacked parental samples so inheritance of the variant is unknown (Nagamani et al. 2009; Bruno et al. 2010; Schiff et al. 2010; Noor et al. 2018). The sixth affected individual was found to have inherited a similar loss from an unaffected parent who was described as being mosaic for the variant (Romano et al. 2020). Similar CNVs have not been reported in controls, however, a deletion of the YWHAE gene has been reported in a single sample (Cooper et al. 2011; MacDonald et al. 2014). Based on the evidence, this CNV is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL CNVClassificationCriteria Aug2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/wisyz6nm/icsl_cnvclassificationcriteria_aug2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Sequence alignment</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" start="1145231" stop="1499243" variantLength="354013" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">1</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10813228</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3992780" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

